LTRN - Lantern Pharma Inc.

QQQ $ 629.16 $ 3.02 (0.48 %)

DIA $ 475.58 $ 0.66 (0.14 %)

SPY $ 681.80 $ 2.23 (0.33 %)

TLT $ 90.21 $ -0.27 (-0.3 %)

GLD $ 368.20 $ -2.01 (-0.54 %)

Previous Close

$ 4.01

Open

$ 3.93

Bid

$ 3.91 x 10

Ask

$ 4.15 x 1,750

Day's Range

$ 3.85 - $ 4.09

52 Week Range

$ 2.55 - $ 6.12

Volume

32,316

Average Volume

Market Cap

43.31M

Beta (5Y Monthly)

$ 1.22

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-13-2025	06-30-2025	10-Q
2	05-15-2025	03-31-2025	10-Q
3	03-27-2025	12-31-2024	10-K
4	11-07-2024	09-30-2024	10-Q
5	08-08-2024	06-30-2024	10-Q
6	05-09-2024	03-31-2024	10-Q
7	03-18-2024	12-31-2023	10-K
8	11-08-2023	09-30-2023	10-Q
9	08-09-2023	06-30-2023	10-Q
10	05-09-2023	03-31-2023	10-Q
11	03-20-2023	12-31-2022	10-K
12	11-07-2022	09-30-2022	10-Q
13	08-08-2022	06-30-2022	10-Q
14	05-03-2022	03-31-2022	10-Q
15	03-10-2022	12-31-2021	10-K
16	11-01-2021	09-30-2021	10-Q
17	07-29-2021	06-30-2021	10-Q
18	05-03-2021	03-31-2021	10-Q
19	03-10-2021	12-31-2020	10-K
20	10-29-2020	09-30-2020	10-Q
21	07-30-2020	06-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Lantern Pharma To Showcase Two Of Its Comm...
10/30/2025 12:11:49

Lantern showcases two commercially ready, machine learning platforms that have the potential to accelerate drug discovery from ...

Lantern Pharma Presents Clinical Data From...
10/28/2025 12:51:06

AI-advanced drug candidate achieves complete metabolic response after two cycles in patient who failed CAR-T and bispecific ant...

Watching Lantern Pharma; Shares Move Highe...
09/30/2025 20:25:38

Trading Halt: Halt status updated at 8:40:...
09/16/2025 12:40:07

Lantern Pharma's LP-184 Meets All Phase 1a...
09/16/2025 12:30:30

LP-184 achieves all primary endpoints and demonstrates a favorable safety and tolerability profile positioning it for both mono...

Trading Halt: Halted at 8:25:00 a.m. ET - ...
09/16/2025 12:25:27

Lantern Pharma Says FDA Confirms Potential...
09/03/2025 13:51:15

Lantern Pharma Completes Type C Meeting Wi...
09/03/2025 13:47:13

Lantern Pharma Inc. (NASDAQ:LTRN), an AI-driven clinical -stage oncology company developing targeted therapies for cancer that ...

12 Health Care Stocks Moving In Thursday's...
08/14/2025 21:06:20

Lantern Pharma Q2 EPS $(0.40) Beats $(0.48...
08/13/2025 20:36:00

Lantern Pharma (NASDAQ:LTRN) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.48...

12 Health Care Stocks Moving In Monday's A...
08/11/2025 21:06:28

12 Health Care Stocks Moving In Thursday's...
08/07/2025 12:07:31

Lantern Pharma's Starlight Therapeutics Re...
08/06/2025 12:32:51

Novel combination therapy with STAR-001 targets the most aggressive and deadliest forms of brain cancer at first progressionGBM...

Lantern Pharma Unveils PredictBBB.ai With ...
08/04/2025 12:56:34

Industry-Leading Platform Achieves 94% Accuracy with Real-Time Machine Learning, Providing Open-Access to Critical CNS Drug Dev...

Lantern Pharma Completes Early Enrollment ...
07/31/2025 11:35:14

Lantern Pharma Inc. (NASDAQ:LTRN), an artificial intelligence (AI) company developing targeted cancer therapies using its propr...

Lantern Pharma Reports Complete Metabolic ...
07/23/2025 11:58:59

AI-guided, synthetic lethal therapy achieves complete metabolic response after just two cycles in patient who failed three prio...

Lantern Pharma Secures EU Patent Allowance...
07/21/2025 12:21:36

The EU patent allowance strengthens the prior patent allowance for LP-284 in the US, Japan India and Mexico.LP-284 has the pote...

Lantern Pharma Launches AI Module Trained ...
07/15/2025 13:42:50

The AI module, trained on 221 clinical trials, will be incorporated as part of Lantern's AI platform, RADR ®, and will init...

12 Health Care Stocks Moving In Tuesday's ...
07/08/2025 12:07:32

Lantern Pharma Enters $15.53M At-The-Marke...
07/03/2025 20:14:05

On July 3, 2025, Lantern Pharma Inc., a Delaware corporation (the "Company"), entered into an ATM Sales Agreement (the ...